Abstract:The microtubule-associated Tau protein aggregates into insoluble paired helical filaments (PHFs) that deposit as neurofibrillary tangles (NFTs) which may cause neurodegeneration in brains of those with Alzheimer's disease(AD) and other related tauopathies; therefore, the drug discovery targeting on Tau protein has attracted an increasing number of researchers. In the last decade, most of the studies were focused on the approach to search for inhibitors of phosphorylation kniases, while only few put their eyes on the approach to discover inhibitors of Tau self-aggregation process. Phenylthiazolyl-Hydrazide (PTH) with the same core structure is a kind of molecules that directly inhibit Tau self-aggregation process. To illuminate the relationship between the structure of R-groups and molecular activities, and design new molecules with higher activity than the template molecule, topomer CoMFA was employed in three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of 26 phenylthiazolyl-hydrazides(PTH) derivatives as Tau protein inhibitors. The Topomer CoMFA model has good fitting ability and predictive ability. The number of principal components, r(2), q(2) r(pred)(2), SEE and F of the Topomer CoMFA model were 5, 0. 976, 0. 603, 0. 795, 0. 110 and 115. 778, respectively. The model was used to search R-groups with special activity contribution from ZINC database. By No. 1 molecule filtering, there were 9 R-1-groups and 2 R-2-groups with contribution values rising by 20%. We employed the 9 R-1-groups and 2 R-2-groups to alternately substitutes for the R-1 and R-2 of sample 1; as a result, we got a total of 18 new compounds and further predicted their activities using the Topomer CoMFA model obtained, and the activity of 15 of them were higher than that of the template molecule. This research showed that Topomer search could be effectively used in molecular design; meanwhile, the molecules designed provide new candidate drugs for drug development of Alzheimer's disease.

Molecular Design of Boric Acid Derivatives of Tyropetin Inhibitors Using R-Group Search Technology

Molecular Docking,3D-QSAR,and Molecular Design of Boronic Acid Derivatives of Tyropeptin Inhibitors of 20S Proteasome

3D-QSAR Study on 2,3-Dihydroimidazo[4,5]-pyridin-2-one Derivatives with a Meta Substitution Pattern As V600E BRAF Inhibitors

Design, Synthesis and Biological Evaluation of Novel Non-peptide Boronic Acid Derivatives As Proteasome Inhibitors

3D-Qsar and Docking Studies of 4-Morpholinopyrrolopyrimidine Derivatives As Potent Mtor Inhibitors

Novel Transforming Growth Factor-Beta Receptor 1 Antagonists through a Pharmacophore-Based Virtual Screening Approach

Design, Synthesis, Biological Evaluation, and Structure-Activity Relationship (sar) Discussion of Dipeptidyl Boronate Proteasome Inhibitors, Part I: Comprehensive Understanding of the Sar of Alpha-Amino Acid Boronates

Discovery, structural optimization, and anti-tumor bioactivity evaluations of betulinic acid derivatives as a new type of RORγ antagonists

Design, synthesis and in vitro evaluation of tylophorine derivatives as possible anti-tumor agents.

In Silico Design of New B-Raf Kinase Type-II Inhibitors Through Combined Molecular Modeling Studies

Combined 3D-Quantitative Structure-Activity Relationships and Topomer Technology-Based Molecular Design of Human 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors.

Molecular Design of PTH Derivatives as Tau Protein Inhibitors Using R-Group Search Technology

Design, synthesis and structure-activity relationship of diaryl-ureas with novel isoxazol[3,4-b]pyridine-3-amino-structure as multi-target inhibitors against receptor tyrosine kinase.

3D-QSAR, molecular docking, and new compound design of pyrimidine derivatives as Src small molecule inhibitors

Design Some New Type-I C-Met Inhibitors Based on Molecular Docking and Topomer Comfa Research

Design, Synthesis and Biological Evaluation of Tripeptide Boronic Acid Proteasome Inhibitors

Design, Synthesis and Biological Evaluation of Β-Carboline Derivatives As Novel Inhibitors Targeting B-Raf Kinase

Design, Synthesis and Antitumor Evaluation of a New Series of N-substituted-thiourea Derivatives

Design, synthesis and biological evaluation of biphenyl urea derivatives as novel VEGFR-2 inhibitors

Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors.

Design, Synthesis and Biological Activity of Bicyclic Carboxamide Derivatives As TRK Inhibitors